Abstract
We evaluated the clinical response to low-dose etoposide in relapsed acute lymphoblastic leukemia (ALL). Of the 45 patients with ALL in first bone marrow relapse enrolled on the ALL R15 protocol, 44 had received epipodophyllotoxins during frontline therapy. In the first week of remission induction therapy, patients received etoposide (50 mg/m(2) per day) administered orally as a single agent once or twice daily. On Day 8, patients started to receive dexamethasone, vincristine, and L-asparaginase. Etoposide was administered until Day 22. Two courses of consolidation therapy were followed by continuation therapy or hematopoietic stem cell transplantation. After 7 days of single-agent etoposide treatment, peripheral blast cell counts (P=0.013) and percentages of bone marrow blasts (P=0.016) were significantly reduced. In all, 38 (84.4%) attained second remission. Only time to relapse was significantly associated with outcome (P=0.025): the 5-year event-free survival estimates (+/-se) were 52.0+/-9.6% for those with late relapse and 20.0+/-8.0% for those with early relapse. We conclude that low-dose etoposide administered orally has a cytoreductive effect in relapsed ALL.
References
Nov 25, 1975·The Journal of Comparative Neurology·C H Yorke, V S Caviness
Sep 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M L SlevinP F Wrigley
Apr 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J D Hainsworth, F A Greco
Sep 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V J LandD J Pullen
Feb 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M V RellingW E Evans
Dec 1, 1996·Medical and Pediatric Oncology·S A FeigR E Harris
Dec 18, 1996·Journal of the National Cancer Institute·C L ChenM V Relling
Feb 19, 1998·The New England Journal of Medicine·W E EvansC H Pui
Feb 21, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A DavidsonC R Pinkerton
Aug 8, 1998·British Journal of Haematology·J M Chessells
Mar 23, 1999·Leukemia·M D AmylonS B Murphy
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B H KushnerN K Cheung
Aug 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B GlissonH Wagner
Feb 24, 2001·Leukemia·C H PuiW E Evans
Aug 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R M BremnesUNKNOWN Norwegian Lung Cancer Study Group
Oct 25, 2001·Lancet·C EckertG Henze
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mathew J EdickMary V Relling
Sep 13, 2003·Blood·Shinji KishiMary V Relling
Dec 25, 2003·Thrombosis Research·Uma H Athale, Anthony K C Chan
Feb 26, 2004·Leukemia·E Coustan-SmithD Campana
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter L GreenbergJacob M Rowe
Apr 9, 2004·The New England Journal of Medicine·Ching-Hon PuiJames R Downing
Citations
Jan 17, 2012·Journal of Pediatric Hematology/oncology·Ulla M Saarinen-PihkalaMerja Möttönen
Aug 14, 2012·Paediatric Drugs·Alissa MartinNobuko Hijiya
Dec 5, 2009·Nanomedicine·Meena MahmoodVladimir P Zharov
Apr 30, 2013·Indian Journal of Pediatrics·Sandeep Jain, Gauri Kapoor
Oct 1, 2005·Leukemia & Lymphoma·Akiko MutoMasahito Tsurusawa
Dec 17, 2008·Cancer·Nobuko HijiyaMelissa M Hudson
Mar 6, 2008·Cancer·Nobuko HijiyaAmar Gajjar
Sep 17, 2014·Transfusion Medicine·S KobayashiA Kikuta
Aug 23, 2005·Cancer Chemotherapy and Biological Response Modifiers·Peter H Wiernik
Apr 19, 2016·Future Oncology·Barbara Asselin
Dec 21, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ulla M Saarinen-PihkalaGöran Gustafsson
Mar 13, 2019·Genes, Chromosomes & Cancer·Joanna MadzioWojciech Mlynarski
May 18, 2011·Pediatric Blood & Cancer·Adriana BalduzziArend von Stackelberg
Jun 18, 2019·Pediatric Blood & Cancer·Raja Pramanik, Sameer Bakhshi
Sep 19, 2019·Pediatric Hematology and Oncology·Rebecca RonsleyKirk R Schultz
Sep 25, 2020·Asia-Pacific Journal of Clinical Oncology·Somsak PrasongtanakijSuradej Hongeng
Jun 28, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Yin Ting CheungKevin R Krull